NA

Naushad Ali Khan

Active Director Director DIN 09697053
DIN 09697053 First appointment Aug 2022 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Naushad Ali Khan

Data last updated:

Naushad Ali Khan is a Director at Patli Mediserve Private Limited (since 2022). The company operates in Service. Patli Mediserve Private Limited reported revenue of ₹1.4 Lakh (FY 2023).

DIN 09697053
Primary Designation Director
Industry Service
First Appointment 05 Aug 2022
Oldest Company Age 4 yrs
Largest company Patli Mediserve Private Limited · ₹1.4 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Patli Mediserve Private Limited U93090BR2022PTC059341
Director05 Aug 20222022₹1.4 Lakh (FY 2023)Active

Board colleagues of Naushad Ali Khan

Directorship timeline

Open interactive timeline →
Patli Mediserve Private Limited
Premium access

Shareholding and investment profile for Naushad Ali Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naushad Ali Khan

Naushad Ali Khan currently holds 1 directorship: Patli Mediserve Private Limited (Director, since 05 Aug 2022, revenue ₹1.4 Lakh (FY 2023)).

Naushad Ali Khan was first appointed on 05 Aug 2022 as Director at Patli Mediserve Private Limited.

The current boards of Naushad Ali Khan's companies include Noshaba Khatun (Patli Mediserve Private Limited), Sunil Kumar (Patli Mediserve Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available